Adjuvant Nivolumab Therapy for MIBC: Safety and Efficacy Data from CheckMate 274

Dr Terence Friedlander explains safety and efficacy data from the CheckMate 247 trial, which led to the FDA approval of adjuvant nivolumab for patients with MIBC.

Related Videos
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Hope Rugo, MD, FASCO, an expert on breast cancer
Related Content